BSE Live
Jan 23, 16:01Prev. Close
458.10
Open Price
458.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:48Prev. Close
458.00
Open Price
460.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
440.25 (137)
| Profit & Loss account of Thyrocare Technologies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 626.68 | 520.29 | 477.62 | 554.59 | 468.96 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 626.68 | 520.29 | 477.62 | 554.59 | 468.96 | |
| Total Operating Revenues | 633.10 | 524.02 | 486.46 | 561.53 | 474.27 | |
| Other Income | 13.34 | 7.18 | 5.39 | 7.40 | 12.28 | |
| Total Revenue | 646.44 | 531.20 | 491.85 | 568.93 | 486.55 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 177.28 | 155.39 | 150.06 | 161.79 | 159.18 | |
| Purchase Of Stock-In Trade | 2.00 | 2.47 | 6.11 | 4.32 | 1.09 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.81 | -0.28 | 0.20 | -0.88 | 0.28 | |
| Employee Benefit Expenses | 118.56 | 102.92 | 102.61 | 58.82 | 56.79 | |
| Finance Costs | 2.63 | 3.73 | 2.25 | 2.38 | 0.66 | |
| Depreciation And Amortisation Expenses | 46.52 | 39.11 | 34.08 | 28.47 | 21.08 | |
| Other Expenses | 147.43 | 129.64 | 115.47 | 106.65 | 86.19 | |
| Total Expenses | 495.23 | 432.98 | 410.78 | 361.55 | 325.27 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 151.21 | 98.22 | 81.07 | 207.38 | 161.28 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 151.21 | 98.22 | 81.07 | 207.38 | 161.28 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 47.77 | 30.03 | 30.17 | 56.21 | 44.25 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 7.66 | -2.95 | -6.07 | -0.88 | -2.74 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 55.43 | 27.08 | 24.10 | 55.33 | 41.51 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 95.78 | 71.14 | 56.97 | 152.05 | 119.77 | |
| Profit/Loss From Continuing Operations | 95.78 | 71.14 | 56.97 | 152.05 | 119.77 | |
| Profit/Loss For The Period | 95.78 | 71.14 | 56.97 | 152.05 | 119.77 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 17.95 | 13.44 | 10.77 | 28.75 | 22.66 | |
| Diluted EPS (Rs.) | 17.90 | 13.41 | 10.75 | 28.70 | 22.62 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 95.27 | 79.35 | 79.31 | 52.84 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 210.00 | 180.00 | 180.00 | 150.00 | 250.00 |
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
24.10.2025
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
24.07.2025
Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss